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ABSTRACT
Objective: To evaluate the relationship between total and differential White Blood Cells (WBC) 
counts with time to transition to type 2 diabetes in Mexican Americans using prospective data 
from the Cameron County Hispanic Cohort (CCHC).
Results: Multivariable Cox proportional hazards regression models revealed that obese Mexi-
can-American cohort participants whose total WBC count or granulocyte count increased over 
time had 1.39 times higher risk and 1.35 times higher risk respectively of transition to type 2 
diabetes when compared to overweight participants. The granulocyte or total WBC count in 
participants with BMI>=35 were significant risk factors for transition to type 2 diabetes.
Conclusions: Increased total WBC and WBC differential counts, particularly lymphocytes 
and granulocytes, are associated with risk of transition to type 2 diabetes in obese Mexican 
Americans, after adjusting for other potential confounders. Screening and monitoring the WBC 
counts, including lymphocytes and granulocytes can help with monitoring potential transition 
to type 2 diabetes. 
KEYWORDS: Type 2 diabetes; BMI; WBC; Cox proportional hazards regression; Effect modi-
fication; Statistical interaction.
ABBREVIATIONS: WBC: White Blood Cells; CCHC: Cameron County Hispanic Cohort; Il-6: 
Interleukin 6; IL-8: Interleukin 8; CRP: C-reactive protein; BMI: Body Mass Index; CRU: 
Clinical Research Unit; ADA: American type 2 diabetes association; IFG: Impaired Fasting 
Glucose; VIF: Variance Inflation Factors; HR: Hazard Ratio.
INTRODUCTION
 The prevalences of obesity and type 2 diabetes in the United States (US) are high. 
More than one-third of US adults are obese, but age-adjusted obesity in Hispanics is high-
er at 42.5%. In 2014, 9.3% of the US population was reported to have type 2 diabetes but 
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the age-adjusted rate of diagnosed type 2 diabetes in Mexican 
Americans nationally was also higher at 13.9%.1 CCameron 
County, Texas is a USA-Mexico border community with 80.5% 
Mexican Americans2 where we have a community-based cohort, 
the Cameron county Hispanic cohort (CCHC). Data from this 
cohort shows that the Cameron county population is character-
ized as having extremely high rates of obesity, type 2 diabetes, 
cardiovascular disease along with metabolic complications and 
other diseases.3-8 Obesity is a strong risk factor for type 2 dia-
betes9 and also plays a significant role in development of low-
grade inflammation.10 It has been shown that many low-grade 
inflammatory markers, including elevated levels of Interleukin 
6 (Il-6), Interleukin 8 (IL-8), C-reactive protein (CRP) and Tu-
mor Necrosis Factor alpha (TNF-α), are associated with insulin 
resistance and type 2 diabetes.11 Total white blood cell (WBC) 
count is another inflammatory marker which has been shown 
to be associated with obesity, impaired glucose tolerance, car-
diovascular diseases and type 2 diabetes.12,13 However, there 
are a few studies that demonstrate association of inflammatory 
markers with development of type 2 diabetes.14-16 In particular, in 
some studies total WBC count and/or WBC differential counts, 
lymphocytes and granulocytes, were found to be independent 
risk factors for development of type 2 diabetes.17-22 In addition, 
the studies of total WBC counts and WBC differential counts 
and development of type 2 diabetes were conducted in different 
populations with respect to gender, ethnicity, and glycemic sta-
tus; however there is no information of how total and differential 
WBC counts are associated with transition to type 2 diabetes in 
Mexican-American people of mixed European and Amerindian 
ancestry. 
 The aim of our study was to assess potential additive 
associations of total and differential WBC counts (lympho-
cytes, monocytes, and granulocytes), CRP, and Body Mass In-
dex (BMI) with time to transition to type 2 diabetes in Mexican 
Americans using prospective data from the Cameron County 
Hispanic Cohort. We further evaluated effect modification of 
BMI and BMI levels on (a) total WBC counts, (b) lymphocytes, 
(c) monocytes, and (d) granulocytes, and (e) CRP in association 
with time to transition to type 2 diabetes. 
METHODS
Study Population 
 The Cameron County Hispanic Cohort (CCHC), as 
previously described,4 was initiated in Cameron County, Texas 
in 2004 and now numbers more than 3000 participants of age 
18 years or older. The initial purpose of the Cohort was to ad-
dress the burden of chronic diseases such as obesity and type 2 
diabetes and their related conditions in Mexican-Americans, one 
of the fastest growing ethnic groups in the United States. The 
participants in this nested study were drawn from the CCHC and 
included on the basis of completion of two or more visits, as fol-
lows: (1) participants in a nested study, the type 2 Diabetes Risk 
Study (DRS), consisting of cohort participants with pre diabetes, 
but not type 2 diabetes, at their initial visit (fasting blood glucose 
100 to 125 gm/dl) and who then visited quarterly over 5 years, 
or (2) participants visiting the CRU for their regularly scheduled 
5- or 10-year follow up visits. Six hundred and thirty six partici-
pants fulfilled the inclusion criteria and their data were therefore 
admitted to this study.
Data Collection
 At their first visit all CCHC participants who agreed to 
participate in the cohort provided written informed consent in-
cluding permission to be contacted for further studies and to visit 
again in 5 year intervals. After agreeing to join the DRS nested 
study a further consent form was signed by participants. All par-
ticipants visited the Clinical Research Unit (CRU) where they 
received detailed physical evaluations and responded to ques-
tionnaires in either Spanish or English by choice. Socio-demo-
graphic and clinical characteristics, biomarkers, family medical 
history and medications were assessed by trained staff members4 
and serial measurements of the variables were routinely entered 
into the database. Biological specimens and questionnaires were 
obtained at all visits according to standard CCHC protocols.4
 The institutional review boards (IRBs) at The 
University of Texas Health Science Center and the University 
of Texas at Brownsville reviewed and approved the protocol and 
the informed consent forms with permissions to collect and store 
de-identified data and specimens for this and other studies.
Outcome Variable
 The outcome variable of interest was time to first tran-
sition from no diabetes and pre-diabetes to type 2 diabetes. The 
time variable, measured in months, was created as the interval 
between the date of the follow-up visits and baseline visit. All 
participants without any evidence of type 2 diabetes after the 
baseline visit, death or lost-to-follow up were censored at their 
last observation dates. Type 2 diabetes was defined by the 2010 
definitions of the American type 2 diabetes association (ADA)23 
and includes a glycated Hemoglobin (HbA1c) of 6.5% or greater 
and or a fasting blood glucose >126 mg/dl. Participants were 
categorized to have type 2 diabetes if they answered that they 
had been told by a health care provider that they have type 2 
diabetes, or if they were taking hypoglycemic medications or 
their laboratory findings met the 2010 ADA criteria for type 2 
diabetes. 
Independent Variables
 The independent variables of interest were BMI, to-
tal and differential WBC counts (lymphocytes, monocytes, and 
granulocytes), and C-reactive protein (CRP) measured at the 
time of the event or censoring. Other covariates, such as age at 
the time of the event or censoring, gender, family history of type 
2 diabetes, pre-diabetes status, smoking, and triglycerides were 
included in the regression analysis. Body mass index (BMI) was 
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calculated as weight in kilograms divided by height squared in 
meters (kg/m2). Height was measured to the nearest 10th cm us-
ing a stadiometer. Weight (to the nearest tenths of a kilogram) 
was measured on a calibrated beam balance. BMI groups were 
created as BMI<25 (normal), 25≤BMI<30 (overweight), and 
BMI≥30 (obese). Family type 2 diabetes history (yes/no) was 
defined based on patients’ reported type 2 diabetes status or high 
blood sugar status ever diagnosed for biological father, biologi-
cal mother, or siblings. Pre-diabetes was defined as participant 
having Impaired Fasting Glucose (IFG) between 100 and 126 
mg/dl or HbA1c between 5.7% and 6.5%.
STATISTICAL ANALYSIS
 Descriptive statistics of baseline demographics and 
clinical characteristics were conducted. Categorical variables 
were described using frequency and percentages. Continuous 
variables were described with mean and standard deviation. SI 
units are used throughout.
 Cox proportional hazard regression model was con-
ducted to estimate hazard ratios and 95% confidence intervals 
using person-period data. Since the time to type 2 diabetes 
was right-censored for the participants who did not transition 
to type 2 diabetes, Breslow’s method was used to handle ties 
in the data. We fit several univariable Cox proportional hazard 
regression models for the time to transition to type 2 diabetes 
including for BMI, total WBC counts, WBC differential counts 
and CRP. Next, we fit several multivariable Cox proportional 
hazard models for the time to transition to type 2 diabetes by 
each significant variable total WBC counts, WBC differential 
counts and CRP, while adjusting for (1) BMI, and (2) BMI, age, 
gender, pre-diabetes status, type 2 diabetes family history, smok-
ing and triglycerides.24-27 In addition, the interactions between 
BMI and total WBC counts, and BMI and WBC differential 
counts were tested by including the product of the two variables 
in the models. The statistical significance of the interaction term 
in the models was assessed by the overall chi-square test (for 
interaction with categorical BMI) and the local chi-square test 
statistic of the coefficient estimates, and by using a likelihood 
ratio test for the nested models with and without an interaction 
term. Assessment for multicollinearity between the variables in-
cluded in the models was performed using Spearman correlation 
coefficient and Variance Inflation Factors (VIF). The function 
form of the continuous covariates included in univariable and 
multivariable Cox proportional hazard regression models were 
evaluated and as a result, variable CRP was log-transformed and 
serum triglyceride level was included in the models along with 
its quadratic form. The proportionality assumption of the haz-
ards in the final models was tested graphically using Schoenfeld 
and scaled Schoenfeld residuals. Since family type 2 diabetes 
history and pre-diabetes status did not satisfy the proportional 
hazard assumption, all models that included these two variables 
involved stratified analysis using strata statement in SAS Proc 
PHReg. In the stratified models, the regression coefficients are 
assumed to be the same in each stratum although the baseline 
hazard functions may be different.28 The key assumption of the 
stratified proportional hazards models that the covariates are act-
ing similarly on the baseline hazard function in each stratum was 
tested by using likelihood ratio test.28 Cox-Snell residuals were 
used to assess the overall fit of the final models.
 All statistical analysis was performed using SAS 9.4.29 
All statistical tests were two-sided and were performed using 
significance (alpha) level of 0.05.
RESULTS
 From the original cohort of 3002 subjects, 636 partici-
pants who were diabetes free at a baseline visit and had more 
than one follow-up were included in this study. These 636 sub-
jects did not differ from the rest of the cohort participants in 
terms of gender, age, number of years lived in Brownsville, and 
household income. The maximum observation period was nine 
years and the mean follow-up was 4.4 visits. The participant’s 
main demographic, anthropometric and clinical baseline char-
acteristics are presented in Table 1. The mean (SD) age of par-
ticipants was 44.6(14.04) years. The majority of the participants 
were females (68.5%), born in Mexico (68.9%) and the average 
number of years lived in Brownsville, TX was of 20.7±15.45 
years. More than half of the participants (52%) had no high 
school education and were full-time or part-time employed 
(53%). Only 26.6% of the participants had any form of health 
insurance, and 55% of these had private insurance.
 On average, the participants at a baseline visit were 
overweight and obese with mean BMI 30.6±6.17 (48.8% obese 
and 36.1% overweight). More than half (53.2%) of the partici-
pants had pre-diabetes. Baseline mean WBC count, mean lym-
phocyte, monocyte and granulocyte counts were within the nor-
mal range.
 We observed 107 participants (16.8%) who transi-
tioned to type 2 diabetes over the entire follow-up period. In-
dividuals who transitioned to type 2 diabetes compared to those 
who did not had higher baseline measurements of most clinical 
characteristics measured, with the exception of triglyceride and 
cholesterol levels. They were older with higher BMI and waist 
circumference measurements (Table 1).
 There is a weak (r<0.30) pairwise correlation between 
total WBC count, lymphocytes, granulocytes, monocytes and 
BMI, age, gender, smoking status, family history of type 2 dia-
betes, pre-diabetes, and triglycerides. However, the correlation 
analysis showed that there was a high dependency between 
total WBC counts and granulocytes (r=0.91, p-value<0.0001), 
total WBC counts and lymphocytes (r=0.60, p-value<0.0001), 
and between total WBC counts and monocytes (r=0.51, p-val-
ue<0.0001). A weak positive relationship was found between 
lymphocytes and granulocytes (r=0.31, p-value<0.0001). 
 
 Univariable Cox proportional hazard regression 
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Converted to Type 2 
diabetes n=107
Not Converted     
n=529
Categorical variables n(%) n(%) n(%)
Male 200(31.5) 34(31.8) 166(31.4)
Female 436(68.5) 73(68.2) 363(68.6)
Born in Mexico 438(68.9) 74(69.2) 364(68.8)
USA 198(31.1) 33(30.8) 165(31.2)
With no high school education 328(51.6) 62(57.9) 266(50.3)
With high school education 308(48.4) 45(42.1) 263(49.7)
Employed 334(52.5) 52(48.6) 282(53.3)
Unemployed 302(47.5) 55(51.4) 247(46.7)
Married 429(68.6) 65(60.8) 364(68.9)
Not married 206(32.4) 42(39.2) 164(31.1)
Insured 169(26.6) 33(30.8) 136(25.8)
Uninsured 466(73.4) 74(69.2) 392(74.2)
Smoke 180(28.3) 30(28.0) 150(28.4)
Do not smoke 456(71.7) 77(72.0) 379(71.6)
Normal weight(BMI<25) 96(15.1) 6(5.7) 90(17.0)
Overweight(25≤BMI<30) 229(36.1) 28(26.4) 201(38.1)
Obese(BMI≥30) 309(48.8) 72(67.9) 237(44.9)
Pre-diabetes 337(53.2) 89(83.2) 248(47.1)
No type 2 diabetes 296(46.8) 18(16.8) 278(52.9)
 Continuous variables Mean(SD) Mean(SD) Mean(SD)
Age 44.6(14.0) 47.9(13.2) 44(14.1)
Years of education 11.2(5.3) 10(4.9) 11.5(5.4)
Years lived in Brownsville 20.7(15.5) 23.5(17.1) 20.1(15.1)
Annual Household Income $20, 404($22, 944.3) $16, 195.4($17, 424.0) $21, 221.4($23, 801.6)
Waist circumference(cm) 100.1(13.5) 106.8(15.0) 98.8(12.8)
Hip circumference(cm) 110.1(11.8) 114.2(13.2) 109.2(11.4)
Waist-to-hip ratio 0.9(0.1) 0.9(0.1) 0.9(0.1)
BMI 30.6(6.2) 33.5(7.4) 30(5.7)
Number of White Blood Cells x 109 /L (n=328) 6.4(1.5) 6.9(1.7) 6.3(1.4)
Number of Lymphocytes x 109 /L (n=328) 2.2(0.6) 2.3(0.6) 2.2(0.6)
Number of Monocytes  x 109 /L (n=328) 0.4(0.2) 0.4(0.2) 0.4(0.2)
Number of Granulocytes x 109 /L (n=328) 3.8(1.2) 4.2(1.3) 3.8(1.1)
Triglyceride mmol/L 1.8(1.5) 2.0(1.6) 1.8(1.4)









Mean FBG mmol/L 5.3(0.6) 5.8(0.5) 5.2(0.5)
Low density lipoprotein mmol/L 3.0(0.9) 2.9(0.8) 3.0(1.0)
High density Lipoprotein mmol/L 1.3(0.3) 1.2(0.3) 1.3(0.3)
Total cholesterol mmol/L 5.1(1.1) 4.9(0.7) 5.1(1.2)
HOMA_IR: MMOL_GLUC*ins/22.5 22.2(16.2) 28.8(18.1) 21.0(16.2)
Insulin pmol/l 93.6(65.5) 112.2(66.8) 89.4(64.7)








analysis showed that the total WBC count [HR=1.17, 95% CI 
(1.06-1.28), p-value=0.0011], lymphocytes [HR=1.79, 95% CI 
(1.32-2.42), p-value=0.0002], granulocytes [HR=1.14, 95% 
CI (1.02-1.27), p-value=0.0229], and BMI [HR=1.07, 95% CI 
(1.04-1.10), p-value<0.0001] were significantly associated with 
transition to type 2 diabetes (Table 2). When BMI was mod-
eled as a categorical variable with three levels (normal BMI 
<25, overweight 25≤BMI<30 and obese BMI≥30) the chi-
square test resulted in significant Hazard Ratio (HR) in obese 
compared to normal BMI group [HR=3.95, 95% CI (1.60-9.77), 
p-value=0.003] and in obese compared to overweight group 
[HR=1.77, 95% CI (1.14-2.73), p-value=0.0105]. Using family 
history and pre-diabetes stratified multivariable Cox proportion-
al hazard regression models, after controlling for age, gender, 
smoking status, and triglycerides, the total WBC count, lympho-
cytes, granulocytes, and BMI, remained statistically significant-
ly associated with the development of type 2 diabetes (Table 2). 
 In the multivariable regression models (Table 3), con-
trolled for other potential confounders, there was a significant 
interaction between total WBC counts and continuous BMI 
[HR=1.02, 95% CI (1.00-1.03), p-value=0.0203] which was 
confirmed with log likelihood ratio test for the nested models, 
with and without the interaction term (p-value=0.0439) (Figure 
1). In addition, there was a significant interaction effect between 
granulocytes and BMI [HR=1.02, 95% CI (1.00-1.04), p-val-
ue=0.0147, log likelihood ratio test p-value=0.0331] (Table 3). 
Lymphocytes were significantly associated with development of 
diabetes (Table 3) with HR=1.68 [95% CI (1.22-2.32), p-val-
ue=0.0015].
 In the multivariable Cox regressions conducted with 
BMI as a categorical variable (Table 4) a significant interac-
tion effect was found between BMI and total WBC count (log 
likelihood ratio test p-value=0.0192). The hazard of transition 
Variables
Crude Hazard Ratios for 
developing type 2 diabetes
Adjusted* Hazard Ratios for  
developing type 2 diabetes
HR(95% CI) P value HR(95% CI) P value
Total WBC x 109 /L 1.17(1.06-1.28) 0.0011 1.18(1.07-1.31) 0.0008
Lymphocytes x 109 /L 1.79(1.32-2.42) 0.0002 1.72(1.26-2.35) 0.0006
Monocytes x 109 /L 2.58(0.78-8.56) 0.1226 2.27(0.71-7.31) 0.1692
Granulocytes x 109 /L 1.14(1.02-1.27) 0.0229 1.16(1.04-1.30) 0.0108
log(C reactive protein) 1.12(0.91-1.37) 0.2993 1.11(0.97-1.27) 0.1235
BMI 1.07(1.04-1.10) <0.0001 1.04(1.003-1.09) 0.0365
BMI groups
25≤BMI<30 vs. BMI <25 2.23(0.86-5.79) 0.098 1.96(0.75-5.13) 0.1697
BMI≥30 vs. BMI <25 3.95(1.60-9.77) 0.003 3.15(1.25-7.94) 0.0148
BMI≥30 vs. 25≤BMI<30 1.77(1.14-2.73) 0.0105 1.61(0.99-2.60) 0.0529
*Hazard ratios adjusted for age, gender, smoking, and triglycerides, and stratified by family history for type 2 diabetes and pre-
diabetes status using strata statement in SAS Proc PHReg.
Table 2: Univariable and multivariable Cox proportional hazard regression analyses of time to first type 2 diabetes on follow-up 
measures of total WBC count, WBC count differentials, CRP and BMI using Cameron county Hispanic cohort data, 2003-2014.
Table 3: Multivariable Cox proportional hazard regression models*for time to first type 2 diabetes on follow-up measures of total WBC count, WBC count differentials, CRP and BMI as continuous 
using Cameron County Hispanic Cohort data, 2003-2014.





















HR(95% CI) P value
X 0.67(0.41-1.08) 0.1018 1.68(1.22-2.32) 0.0015 1.85(0.53-6.38) 0.3332 0.58(0.33-1.01) 0.0553 1.04(0.90-1.20) 0.6475
BMI 0.92(0.82-1.03) 0.148 1.05(1.02-1.08) 0.001 1.05(1.02-1.08) 0.0007 0.94(0.85-1.03) 0.1868 1.05(1.02-1.08) 0.0012
X*BMI 1.02(1.00-1.03) 0.0209 1.02(1.00-1.04) 0.0147
Hazard ratio for X by the level of the interacting variable  BMI 
X and BMI=20 0.95(0.77-1.16) 0.89(0.70-1.13)
X and BMI=25 1.03(0.89-1.20) 0.99(0.83-1.17)
X and BMI=30 1.13(1.01-1.26) 1.10(0.96-1.26)
X and BMI=35 1.23(1.09-1.38) 1.23(1.06-1.41)
X and BMI=40 1.34(1.14-1.57) 1.36(1.13-1.65)
*All models were stratified by family history for type 2 diabetes and pre-diabetes status using strata statement in SAS Proc PHReg and adjusted for age, gender, smoking, and triglycerides.
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Figure 1: Simulated adjusted hazard ratio with the 95% probability interval of simulations of total WBC counts by unit increase 
in BMI.
to type 2 diabetes in thousands increase per microliter in total 
WBC count is 1.39[95% CI (1.07-1.81), p-value=0.0127] times 
higher in obese individuals compared to overweight individu-
als. This was also shown graphically in Figure 2 with estimated 
hazard ratios for total WBC counts by BMI levels. The line for 
BMI ≥35 lies above the lines for BMI<25 and 25≤ BMI<35, re-
spectively, and it was crossed with the line for 25≤ BMI<35 but 
paralleled with the line for BMI<25. The local chi-square test 
in the adjusted models showed a significant HR 1.35[95% CI 
(1.01-1.81), p-value=0.0432] for increased levels in thousands 
granulocytes blood cells count per microliter comparing obese 
to overweight individuals (Table 4, Figure 3).
 To further determine if granulocytes and lymphocytes 
were associated independently of each other with transition to 
type 2 diabetes, additional Cox proportional hazards models 
were fitted for (1) granulocytes and lymphocytes together and 
(2) for granulocytes and lymphocytes together controlled for 
BMI, age, gender, smoking status, family history of type 2 dia-
betes, pre-diabetes, and triglycerides. Table 5 shows that lym-
phocytes were independently associated with transition to type 
2 diabetes after controlling for granulocytes and the other poten-
tial confounders. In addition, there was a significant interaction 
between granulocytes and BMI[HR=1.02, 95% CI (1.00-1.04), 
p-value=0.0177, log-likelihood ratio test p-value=0.0189] indi-
cating that the effect of granulocytes on transition to type 2 dia-
betes is different for different values of BMI, after controlling 
for the effect of lymphocytes and the other potential confound-
ers. More specifically, the HR for granulocytes was significant 
when BMI≥35 [HR=1.18, 95% CI (1.01, 1.37)] and the hazard 
ratio increased as the values of BMI increased. 
DISCUSSION
 Prospective data from our Mexican American popu-
lation-based cohort revealed that total white blood cell counts, 
particularly lymphocytes and granulocytes were associated with 
risk of transition to type 2 diabetes. This remains true in both 
crude and controlled analyses using BMI and other potential 
confounders such as age, gender, smoking status, family history 
of type 218 diabetes, pre-diabetes, and serum triglyceride levels. 
Other studies conducted on different populations in respect to 
gender, geographic location, ethnicity, and glycemic status, have 
reported significant relationship between incidence of type 2 
diabetes and the WBC count and WBC count differentials.17-22 In 
a multicenter, multi-ethnic study using a range of glucose toler-
ance levels in USA states population without type 2 diabetes, 
Lozeno, et al. reported a significant association between higher 
lymphocyte counts and incidence of type 2 diabetes, after con-
trolling for smoking, family history of type 2 diabetes, fasting 
blood glucose and BMI but did not find significant association 
between total WBC count and incidence of type 2 diabetes af-
ter controlling for the other covariates.18 In a prospective cohort 
study of young, normoglycemic men with normal WBC counts, 
conducted in Israel, Twig, et al. reported that total WBC count 
was an independent risk factor for development of type 2 dia-
betes after controlling for age, smoking, family history of type 
2 diabetes, fasting blood glucose, triglycerides and BMI.20 In a 
prospective cohort study of Pima Indians with baseline normal 
glucose tolerance, Volzorova, et al. also found total WBC counts 
to be an independent risk factor for development of type 2 dia-
betes, after controlling for age, gender and percent of body fat.17 
Similarly, Jiang, et al. reported that elevated total WBC count 
was independently associated with deterioration in glucose 
metabolism in middle-aged and elderly Chinese.19 In addition, 
neutrophils, which comprise the majority of granulocytes, were 
found significantly associated with incident type 2 diabetes.30
 Although it is hard to compare WBC differentials be-
tween people living in different environments our findings con-
firmed these previous findings that increasing total WBC counts, 
lymphocytes and granulocytes to be independent predictors of 
transition to type 2 diabetes in Mexican Americans when con-
trolling for other potential confounders. Moreover, we further 
examined the presence of statistical interaction effects in the 
Cox proportional hazards regression models, towards better ex-
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*All models were stratified by family history for type 2 diabetes and pre-diabetes status using strata statement in SAS Proc PHReg and adjusted for age, gender, smoking, and triglycerides.
Figure 3: Estimated adjusted hazard ratios for granulocytes by BMI levels.Figure 2: Estimated adjusted hazard ratios for total WBC counts by BMI levels.
Table 4: Multivariable Cox proportional hazard regression models* for time to first type 2 diabetes on follow-up measures of total WBC count, WBC count differentials, CRP and BMI categories using 
Cameron county Hispanic cohort data, 2003-2014.
planation of the development of the type 2 diabetes. Our study 
indicated that total WBC count and granulocytes and BMI were 
jointly associated with development of type 2 diabetes. Higher 
levels of total WBC and granulocyte count were stronger pre-
dictors of incident type 2 diabetes in obese in compare to over-
weight individuals. Similar findings were reported only for total 
WBC counts in the cohort study of young normal glycemic Is-
raeli men conducted by Twig G, et al.20 Our results suggest that 
obese Mexican-American participants with higher levels of total 
WBC count had 1.39 times higher risk of transition to type 2 
diabetes when compared to overweight participants. Likewise, 
obese Mexican-American with higher granulocytes counts had 
1.35 times higher risk of conversion to type 2 diabetes when 
compared to overweight participants. Additionally we showed 
that lymphocyte and granulocyte count are independent risk 
factors for transition to type 2 diabetes, in particular, granulo-
cyte count is a risk factor for categories II and III obese people 
(BMI>=35).
 Though granulocytes (principally neutrophils) are con-
sidered the arm of the innate immune response and lympho-
cytes that of the acquired immune responses, it is now clear that 
there is considerable and complex cross-talk and collaboration 
between cells of both these systems both in acute and chronic 
disease.31 Both these systems are implicated in the chronic in-
flammatory syndrome of type 2 diabetes.32 Infiltration of visceral 
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adipose tissues with neutrophils, macrophages and lymphocytes 
is now recognized to be associated with both obesity and type 2 
diabetes.32-34 Whether this process is associated with increased 
numbers of circulating cells of these lineages is unknown, but in 
Table 2 it is interesting to note that increases in the lymphocyte 
lineages are noticeably associated with development of type 2 
diabetes.32 Overall these observations suggest that it is reason-
able to hypothesize that the increase in total and differential 
WBC counts that we observe may be markers of increase in the 
inflammatory syndrome and increasing insulin resistance prior 
to development of overt type 2 diabetes.32
STRENGTH AND LIMITATIONS
 CCHC data is representative by design of this single 
ethnicity border population characterized with high prevalence 
of type 2 diabetes and other conditions and biomarkers for chron-
ic diseases.3-7 Although many of the participants do not have the 
same follow-up time, the response rate of the CCHC participants 
is high. To our knowledge, this study was the first conducted in 
a Mexican-American population, to assess risk factors leading 
to the development of type 2 diabetes. In addition our study has 
some novel findings that in non-diabetic and pre-diabetic popu-
lation lymphocytes is an independent of granulocytes factor of 
incident type 2 diabetes regardless of the levels of BMI, while 
granulocytes is an independent risk factor when BMI>=35.
 Our study has some limitations. Based on the results 
from the analysis we did not find any association between CRP 
and transition to type 2 diabetes as shown in several studies.35-38 
We did not find any interaction between continuous BMI and 
lymphocytes. The reason is that the study was performed based 
on available data of 636 participants and detecting statistically 
significant smaller interaction effects in the Cox proportional 
hazard regression models may be underpowered.39 Moreover, it 
is known, that larger sample sizes are needed to study interac-
tions involving continuous variables.39
CONCLUSIONS
 Increased total WBC and WBC differential counts, par-
ticularly lymphocytes and granulocytes, are associated with risk 
of transition to type 2 diabetes, particularly among the obese 
Mexican-American, after adjusting for other potential con-
founders. Our study emphasizes the predictive importance of 
total WBC counts, lymphocytes and granulocytes in obese par-
ticipants, in particular the role of lymphocytes and granulocytes. 
Our observations emphasize the central role of chronic inflam-
mation in the pathology of type 2 diabetes, and that this process 
is underway well before diagnosis. Since inflammation plays a 
role in the development of type 2 diabetes understanding its role 
is important in development of prevention strategies for type 2 
diabetes. Since our study suggests that screening and monitoring 
the WBC counts, lymphocytes and granulocytes can help with 
predicting potential transition to type 2 diabetes administering 
anti-inflammatory medications in addition to life-style changes 
may bolster efforts in preventing this disease.
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